S100钙结合蛋白A7(S100A7)检测试剂盒(酶联免疫吸附试验法)
ELISA Kit for S100 Calcium Binding Protein A7 (S100A7)
S100-A7; PSOR1; S100A7c; Psoriasin 1
- 编号SEC035Bo
- 物种Bos taurus; Bovine (Cattle,牛) 相同的名称,不同的物种。
- 实验方法双抗夹心
- 反应时长3h
- 检测范围15.6-1,000pg/mL
- 灵敏度最小可检测剂量小于等于6.0pg/mL.
- 样本类型serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下载 英文说明书 中文说明书
- 规格 48T96T 96T*5 96T*10 96T*100
- 价格 ¥ 3528 ¥ 5040 ¥ 22680 ¥ 42840 ¥ 352800
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
本试剂盒用于检测S100钙结合蛋白A7(S100A7),经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制,不可能完成对所有相关或相似物质交叉反应检测,因此本试剂盒有可能与未经检测的其它物质有交叉反应。
回收率
分别于定值血清及血浆样本中加入一定量的S100钙结合蛋白A7(S100A7)(加标样品),重复测定并计算其均值,回收率为测定值与理论值的比率。
样本 | 回收率范围(%) | 平均回收率(%) |
serum(n=5) | 90-98 | 95 |
EDTA plasma(n=5) | 84-98 | 89 |
heparin plasma(n=5) | 80-91 | 83 |
精密度
精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差:取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次,分别计算不同浓度样本的平均值及SD值。
批间差:选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定,每个样本使用同一试剂盒重复测定8次,分别计算不同浓度样本的平均值及SD值。
批内差: CV<10%
批间差: CV<12%
线性
在定值血清及血浆样本内加入适量的S100钙结合蛋白A7(S100A7),并倍比稀释成1:2,1:4,1:8,1:16的待测样本,线性范围即为稀释后样本中S100钙结合蛋白A7(S100A7)含量的测定值与理论值的比率。
样本 | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 80-99% | 82-101% | 89-96% | 85-92% |
EDTA plasma(n=5) | 90-97% | 93-105% | 88-95% | 91-101% |
heparin plasma(n=5) | 88-96% | 92-101% | 88-103% | 91-99% |
稳定性
经测定,试剂盒在有效期内按推荐温度保存,其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响,实验室的环境条件需尽量保持一致,尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。
实验流程
1. 实验前标准品、试剂及样本的准备;
2. 加样(标准品及样本)100µL,37°C孵育1小时;
3. 吸弃,加检测溶液A100µL,37°C孵育1小时;
4. 洗板3次;
5. 加检测溶液B100µL,37°C孵育30分钟;
6. 洗板5次;
7. 加TMB底物90µL,37°C孵育10-20分钟;
8. 加终止液50µL,立即450nm读数。
实验原理
将S100钙结合蛋白A7(S100A7)抗体包被于96孔微孔板中,制成固相载体,向微孔中分别加入标准品或标本,其中的S100钙结合蛋白A7(S100A7)与连接于固相载体上的抗体结合,然后加入生物素化的S100钙结合蛋白A7(S100A7)抗体,将未结合的生物素化抗体洗净后,加入HRP标记的亲和素,再次彻底洗涤后加入TMB底物显色。TMB在过氧化物酶的催化下转化成蓝色,并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的S100钙结合蛋白A7(S100A7)呈正相关。用酶标仪在450nm波长下测定吸光度(O.D.值),计算样品浓度。
增值服务
相关产品
编号 | 适用物种:Bos taurus; Bovine (Cattle,牛) | 应用(仅供研究使用,不用于临床诊断!) |
RPC035Bo02 | S100钙结合蛋白A7(S100A7)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APC035Bo61 | S100钙结合蛋白A7(S100A7)活性蛋白 | Cell culture; Activity Assays. |
RPC035Bo01 | S100钙结合蛋白A7(S100A7)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPC035Bo61 | S100钙结合蛋白A7(S100A7)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAC035Bo02 | S100钙结合蛋白A7(S100A7)多克隆抗体 | WB |
PAC035Bo01 | S100钙结合蛋白A7(S100A7)多克隆抗体 | WB; IHC; ICC; IP. |
SEC035Bo | S100钙结合蛋白A7(S100A7)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
KSC035Bo01 | S100钙结合蛋白A7(S100A7)检测试剂盒DIY材料(酶联免疫吸附试验法) | Main materials for "Do It(ELISA Kit) Yourself" |
参考文献
杂志 | 参考文献 |
Archives of Dermatological Research | Serum levels of antimicrobial peptides and proteins do not correlate with psoriasis severity and are increased after treatment with fumaric acid esters [SpringerLink: t07u24t43r357l15] |
J Proteome Res | Proteomic Signature of Endothelial Dysfunction Identified in the Serum of Acute Ischemic Stroke Patients by the iTRAQ-Based LC–MS Approach [PubMed: 25807139] |
Exp Dermatol | S100A7 (psoriasin) inhibits human epidermal differentiation by enhanced IL-6 secretion through IκB/NF-κB signaling [Pubmed:27060579] |
Experimental Dermatology | S100A7 (psoriasin) inhibits human epidermal differentiation by enhanced IL‐6 secretion through IκB/NF‐κB signalling [pubmed:27060579] |
Experiental And Therapeutic Medicine | Plasma proteins as potential targets of abnormal Savda syndrome in asthma patients treated with unique Uighur prescription [pubmed:28672924] |
Scientific Reports | The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function. [pubmed:29142248] |
Journal of the European Academy of Dermatology and Venereology | A potential contribution of psoriasin to vascular and epithelial abnormalities and inflammation in systemic sclerosis [Pubmed:28681537] |
Scientific Reports | Measurements of AMPs in stratum corneum of atopic dermatitis and healthy skin–tape stripping technique [Pubmed:29374283] |
Neuroscience Bulletin | Comprehensive proteomic profiling of patients' tears identifies potential biomarkers for the traumatic vegetative state [Pubmed:30019218] |
Journal of Proteomics | Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection [Pubmed: 31706945] |
Mediators of Inflammation | Alarmins HMGB1, IL-33, S100A7, and S100A12 in Psoriasis Vulgaris [] |